True Wealth Design’s RxSight RXST Stock Holding History

True Wealth Design’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.95K	Sell	398 -69	-15%	-$405	﹤0.01%	1691
2026 Q2	$2.25K	Buy	467 +343	+277%	+$2.07K	﹤0.01%	1641
2026 Q1	$764	Buy	124 +81	+188%	+$673	﹤0.01%	1902
2025 Q4	$449	Buy	+43	New	+$431	﹤0.01%	1983
2025 Q3	–	Sell	-4	Closed	-$52	–	2860
2025 Q2	$52	Sell	4 -3	-43%	-$45	﹤0.01%	2373
2025 Q1	$177	Buy	+7	New	+$208	﹤0.01%	2005
2024 Q4	–	Sell	-35	Closed	-$1.73K	–	1494
2024 Q3	$1.73K	Buy	+35	New	+$1.79K	﹤0.01%	830

Other funds holding RXST

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

True Wealth Design's RXST Position: Q3 2026 in Review

True Wealth Design reduced its RxSight (RXST) stake by 15% in Q3 2026, selling an estimated $405 and leaving 398 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

True Wealth Design first reported a position in RXST in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.25K in Q2 2026. 10 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

True Wealth Design held 398 shares of RxSight worth $1.95K as of Q3 2026.
True Wealth Design sold 69 RxSight shares in Q3 2026, an estimated $405.
RxSight made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1691 holding.
True Wealth Design first reported a position in RxSight in Q3 2024 and has held it in 7 quarters since.
True Wealth Design's RxSight position peaked at $2.25K in Q2 2026.
10 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.